Halahleh K - Search Results

1

Halahleh K, Arai Y, Gavriilaki E. Halahleh K, et al. Blood Cell Ther. 2023 Feb 25;6(1):23-29. doi: 10.31547/bct-2022-021. eCollection 2023 Feb 25. Blood Cell Ther. 2023. PMID: 37324567 Free PMC article.

2

The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia.

Halahleh K, Al Rimawi D, Abu Ghosh A, Muradi I, Da'na W, Hamadani M. Halahleh K, et al. Hematol Oncol Stem Cell Ther. 2022 Dec 23;15(4):219-222. doi: 10.1016/j.hemonc.2021.07.003. Hematol Oncol Stem Cell Ther. 2022. PMID: 34352199 No abstract available.

3

Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan.

Ma'koseh M, Amarin R, Tamimi F, Sharaf B, Abufara A, Shahin O, Manassra MKM, Halahleh K. Ma'koseh M, et al. Among authors: halahleh k. Blood Res. 2021 Dec 31;56(4):279-284. doi: 10.5045/br.2021.2021116. Blood Res. 2021. PMID: 34880141 Free PMC article.

4

Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients.

Halahleh K, Al Sawajneh S, Saleh Y, Shahin O, Abufara A, Ma'koseh M, Abdel-Razeq R, Barakat F, Abdelkhaleq H, Al-Hassan N, Atiyyat R, Al-Faker N, Omari Z, Ghatasheh H, Jaradat I, Muradi I, Iyad S, Bazarbachi A. Halahleh K, et al. Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):589-595. doi: 10.1016/j.clml.2022.02.009. Epub 2022 Mar 4. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35490153

5

Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP.

Halahleh K, Yaseen A, Muradi I, Al-Ibraheem A, Sultan I, Ma'koseh M. Halahleh K, et al. J Blood Med. 2023 Feb 20;14:147-157. doi: 10.2147/JBM.S393180. eCollection 2023. J Blood Med. 2023. PMID: 36846350 Free PMC article.

6

[No title available]

[No authors listed] [No authors listed] PMID: 36163844

7

[No title available]

[No authors listed] [No authors listed] PMID: 36164199

8

The Impact of Graft CD3⁺ T-Cell Dose on the Outcome of T-Cell Replete Human Leukocyte Antigen-Mismatched Allogeneic Hematopoietic Peripheral Blood Stem Cells Transplantation.

Halahleh K, Mustafa R, Sarhan D, Al Rimawi D, Abdelkhaleq H, Muradi I, Sultan I. Halahleh K, et al. J Hematol. 2023 Feb;12(1):27-36. doi: 10.14740/jh1071. Epub 2023 Feb 25. J Hematol. 2023. PMID: 36895292 Free PMC article.

9

Analysis of FLT3-Activating Mutations in Patients With Acute Myelogenous Leukemia in Jordan: Association With FAB Subtypes and Identification of Subgroups With Poor Prognosis.

Halahleh K, Taqash A, Abdelkhaleq H, Manasrah M, Marie L, Al-Rabi K. Halahleh K, et al. Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):e588-e597. doi: 10.1016/j.clml.2021.02.006. Epub 2021 Mar 9. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33811005

10

Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.

Halahleh K, Muradi I, Khalil MZ, Halahleh L, Sughayer M, Kamal N, Sultan I, Alrabi K. Halahleh K, et al. Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):e411-e419. doi: 10.1016/j.clml.2023.08.007. Epub 2023 Sep 6. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37730482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page